🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you to SPARK NS for helping us turn the ubiquitin system against Parkinson's Disease! Kudos to UC Berkeley MCB Molecular Therapeutics Initiative Molecular Therapeutics Initiative student Srividya Chandrasekhar and postdoc Josh Sheetz for their groundbreaking work! sparkns.org/programs/proje…

Huge congratulations to Stephen Hauser UC San Francisco - so well deserved for amazing science by an equally amazing community builder Weill Neurohub

One of the best things of teaching (and doing research) at UC Berkeley is our environment. Huge thanks to Arnav Metha of The Column Group, who taught our Molecular Therapeutics Initiative grad students the ins and out of clinical trials!

Big congratulations to one of our #MolecularTherapeutics superstars, James Olzmann !

Huge thank you to Leon Chen, Partner at The Column Group, for teaching our #MolecularTherapeutics graduate students the ins and outs of biotech today! UC Berkeley 🙏

Congratulations to this year's MTI innovation awardees! Including UC Berkeley MCB graduate student Rumi Sherriff, who came up with an amazing idea to harness ubiquitin for therapeutic benefit #MolecularTherapeutics 💪

Thrilled to contribute to this exciting project conceptualized and led by graduate student extraordinaire Rumi Sherriff !! 👏

We are pleased to announce that NRIX’s Chief Scientific Officer, Gwenn Hansen, Ph.D., is a guest speaker at the AACR-CICR Working Group Town Hall being held during the 2025 AACR Annual Meeting on Monday, April 28, 2025, from 6:30-8:30 p.m. CT. bit.ly/41LqxGd

$NRIX’s Dir. of Preclinical Pharmacology Alexandra ‘Sasha’ Borodovsky, Ph.D., will present a poster highlighting preclinical data from Nurix’s BRAF degrader NRX-0305 at the 2025 AACR Annual Meeting on Mon, Apr 28, 2025, at 9:00 a.m. CT. Check out the poster session!

Wonderful talk by Rushika M. Perera of University of UC San Francisco today in our Molecular Therapeutics Initiative /#MolecularTherapeutics seminar series at UC Berkeley today, presenting cool data about organ-selective metastasis! Thank you!!!

$NRIX’s Exec. Dir. of Medicinal Chemistry, Wylie Palmer, Ph.D., will present a poster highlighting Nurix’s BTK degrader NX-5948 at the 2025 AACR Annual Meeting on Wednesday, April 30, 2025, at 9:00 a.m. CT. If you’re attending #AACR2025, check out the poster session.

Excited to host Gerta Hoxhaj Lab for a visit to UC Berkeley tomorrow. If you are on campus, come by for her seminar. It is going to be AWESOME! 🤩

Ryan Rountree Nurix Therapeutics sharing data from their Aurora A #PROTAC program delivering lead NRX-4972 with high selectivity over Aurora B, CRBN-dependency, oral bioavailability & in vivo efficacy. #AACR25 AACR

Congratulations to #MolecularTherapeutics faculty and Molecular Therapeutics Initiative member Markita Landry on winning a Guggenheim Fellowship! So cool to work with such amazing colleagues on a daily basis! news.berkeley.edu/2025/04/22/two…

Excited to host Brent Stockwell for a seminar tomorrow in the UC Berkeley MCB Molecular Therapeutics Series! If you are on campus come by for an exceptional seminar on recent advances on our understanding and targeting of #ferroptosis! 😀

Thank you to Brent Stockwell of Columbia University for visiting #MolecularTherapeutics at Molecular Therapeutics Initiative UC Berkeley MCB and presenting a tour-de-force through the ferroptosis field!

🧠 What if we could see depression at the molecular level - and shut it off at the source? 2025 MTI Innovator Awardee Dr. Ehud Isacoff is developing FRET-based screens to find precise modulators of glutamate receptors - a new path to fast-acting antidepressants. The future of

🧫 What if cancer’s most essential machinery had never been drugged - simply because it was too complex? 2025 MTI Innovator Dr. Jim Hurley is pioneering a new wave of cancer therapeutics by targeting the ESCRT system - a core survival pathway in dividing cells. #MTIAwards

Excited that our work revealing the structure and function of the monster stress response silencing factor, the E3 ligase SIFI, is now out! Congratulations to the most amazing team of Zhi Yang, Diane Haakonsen, Michael Heider and Sam Witus! nature.com/articles/s4158…

🌍What if we could paralyze parasites - without harming human cells? 2025 MTI Innovator Dr. Matt Welch is targeting kinesin motor proteins in Trypanosoma brucei to develop new therapies for African sleeping sickness and other neglected diseases. New hope for the world’s most